Lupus: Clinical Trials

6 trials for Lupus, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 26Completed 6

Follow Lupus: new trials by email Literature Review of Lupus trials Research Report on Lupus

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
JBT-101 in Systemic Lupus Erythematosus (SLE)
JBT-101, Placebo - Systemic Lupus Erythematosus, SLE
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)1092017-12-212026-05-06
Safety and Efficacy Study of a Biologic to Treat Systemic Lupus Erythematosus
BMS-931699, Placebo matching BMS-931699 - Lupus
Phase 2CompletedBristol-Myers Squibb7302014-11-132019-10-07
Vitamin D3 in Systemic Lupus Erythematosus
Vitamin D3, Vitamin D3 placebo - Systemic Lupus Erythematosus, SLE
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)572008-11-012017-04-26
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus
MEDI-545, Placebo - Lupus Erythematosus, Systemic, Lupus
Phase 2CompletedMedImmune LLC872008-07-012016-08-09
Improving Quality of Life for African American Female Adolescents With Lupus
Coping skills and cognitive restructuring techniques, Educational training - Lupus
Phase 2CompletedMedical University of South Carolina1202004-04-012018-05-09
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
pravastatin, aspirin, ramipril - Systemic Lupus Erythematosus, Lupus
Phase 2CompletedBrigham and Women's Hospital1502003-03-012013-12-24

Narrower conditions

Lupus Erythematosus, Systemic (4)  ·  Musculoskeletal Diseases (1)  ·  Vitamin D Deficiency (1)

Broader conditions

Autoimmune Diseases (4)  ·  Connective Tissue Diseases (4)  ·  Immune System Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Avitaminosis (1)  ·  Deficiency Diseases (1)  ·  Malnutrition (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Aspirin (1)  ·  Cholecalciferol (1)  ·  Coping Skills (1)  ·  Folic Acid (1)  ·  Pravastatin (1)  ·  Ramipril (1)  ·  Training Support (1)  ·  Vitamin B 12 (1)  ·  anabasum (1)  ·  lenabasum (1)  ·  lulizumab pegol (1)  ·  sifalimumab (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Brigham and Women's Hospital (1)  ·  Bristol-Myers Squibb (1)  ·  MedImmune LLC (1)  ·  Medical University of South Carolina (1)

Countries

United States (6)  ·  Argentina (1)  ·  Brazil (1)  ·  Canada (1)  ·  Chile (1)  ·  Colombia (1)  ·  France (1)  ·  Germany (1)  ·  Hungary (1)  ·  Italy (1)  ·  Japan (1)  ·  Lebanon (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Peru (1)

Top investigators

Cynthia Aranow, MD (1)  ·  Diane Kamen, MD (1)  ·  Matthew H. Liang, MD, MPH (1)  ·  Meggan Mackay, M.D., M.S. (1)  ·  Robert B. Zurier, M.D. (1)  ·  Ronald T. Brown, PhD (1)  ·  Warren Greth, M.D. (1)

Results publications

PMID 16208639, PMID 21798883, PMID 25777546, PMID 33687069

NIH funding

2014 (1), P60AR047782 (1), P60AR049459 (1), UM1AI110494 (1)